SKBI...BTW, organic growth alone has been running at 40%+. Even if organic growth slows a notch, $3 EPS+ is doable considering the acquisitions and the vaccine facility. I just don't understand why analysts are coming in w/ such low EPS numbers for 2011?? What am I'm missing? We'll see what happens...
The information posted by 2morrowsGains is opinion only and should not to be taken as investment advice.